Please note that as of November 25, 2024, the global shortage of molybdenum-99 has been resolved. As such, healthcare providers should resume normal diagnostic care of their patients, including tests such as cardiac stress tests and bone scans.
EviCore is continually working to enhance your prior authorization (PA) experience by streamlining and enhancing our overall PA process. You may notice incremental enhancements to our online interface and case-decision process. Should you have feedback regarding your experience, please provide it in the Web Feedback online form.